Humane Genomics
ActiveA platform to make artificial viruses as cancer therapeutics.
What it does
Humane Genomics has developed a platform to engineer cancer killing viruses. We have taken a first principles approach to design and make oncolytic viral therapies. Using a highly lytic RNA virus engineered with "2 factor authentication" (using selective infection and selective replication) they have an on-target to off-target kill ratio > 1000. We are working on our first indication, pediatric liver cancer (hepatoblastoma), with our partners at Texas Children's Hospital, who are world leading experts. We have in vivo (mouse) data showing safety and currently developing efficacy data and are showing 50% reduction in tumor volume.
Its site says now · captured 2026-08-23
Home - Humane Genomics
Humane Genomics develops cancer therapies by engineering cancer-killing RNA viruses using a synthetic biology platform.
Next to it in Healthcare and bio · oncolytic viral cancer therapeutics
- TippingPoint BiosciencesSOSV SOSV IndieBio SF 14
First ever therapeutics for cancers driven by aberrant chromatin networks
- SFA TherapeuticsY Combinator S21
Regulating the immune system to block cancer & autoimmune diseases
- AOA DxY Combinator S21
Blood Test for Early Detection of Ovarian Cancer
- DigistainY Combinator S21
Pioneering Breast Cancer Diagnostics for a Healthier Tomorrow
- MatrubialsY Combinator S21
Developing milk-inspired therapeutics for infectious diseases
- Promakhos TherapeuticsY Combinator S21
A therapeutics platform for curing inflammatory disorders
- ViAn TherapeuticsSOSV SOSV IndieBio SF 14
Topical antiangiogenic peptide for retinal vascular diseases
- Felix BiotechnologyY Combinator W20
We’re creating programmable therapies